Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Conavi Medical Corp (CNVI.VN)

Conavi Medical Corp (CNVI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 44,469
  • Shares Outstanding, K 103,417
  • Annual Sales, $ 9,122 K
  • Annual Income, $ -20,516 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales 39.66
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.36
  • Most Recent Earnings $-0.09 on 02/26/26
  • Next Earnings Date 04/07/25
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING:

    TSX Medical Devices

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.350 +20.00%
on 03/04/26
0.450 -6.67%
on 03/06/26
+0.015 (+3.70%)
since 02/09/26
3-Month
0.350 +20.00%
on 03/04/26
0.570 -26.32%
on 01/06/26
-0.080 (-16.00%)
since 12/09/25
52-Week
0.350 +20.00%
on 03/04/26
0.710 -40.85%
on 03/18/25
-0.270 (-39.13%)
since 03/07/25

Most Recent Stories

More News
Conavi Medical Reports Fiscal First Quarter 2026 Results and Operational Highlights

- Successfully Closes $12M Public Offering,  Strengthens Balance Sheet and Supports Anticipated U.S. Launch - Recent Peer-Reviewed Publication Demonstrates Advantages of Hybrid IVUS-OCT Imaging TORONTO,...

CNVI.VN : 0.420 (-2.33%)
CNVIF : 0.3130 (+4.06%)
Conavi Medical Highlights Peer-Reviewed Publication Demonstrating Advantages of Hybrid IVUS-OCT Imaging

TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”), a leader in hybrid intravascular imaging technologies, today highlighted the publication of new peer-reviewed...

CNVI.VN : 0.420 (-2.33%)
CNVIF : 0.3130 (+4.06%)
Upcoming Meeting Dates - January 26, 2026

Toronto, Ontario--(Newsfile Corp. - January 26, 2026) - The following is a list of Upcoming Meeting Dates announced this week for Reporting Issuers in Canada. The data is supplied by Issuing Companies...

EQB.TO : 118.49 (-0.45%)
PRME.CN : 0.0650 (+8.33%)
SKRR.VN : 0.250 (-5.66%)
CYF.VN : 0.035 (+16.67%)
NOP.CN : 0.1250 (unch)
AIML.CN : 0.0350 (unch)
CRI.VN : 0.135 (+8.00%)
BLN.TO : 7.03 (+0.43%)
ATI.VN : 0.015 (-25.00%)
PPX.VN : 0.300 (-1.64%)
DFSC.VN : 3.140 (-3.38%)
LOT.VN : 0.060 (unch)
Conavi Medical Reports Fiscal Year 2025 Results and Operational Highlights

Next-Generation Novasight Hybrid™ System Submitted to U.S. FDA for 510(k) Clearance U.S. and European Class 1A Guidelines Reinforce Growing Adoption of Image-Guided PCI Peer-Reviewed Publications...

CNVI.VN : 0.420 (-2.33%)
CNVIF : 0.3130 (+4.06%)
Conavi Expands Leadership Team to Support Next Phase of U.S. Commercialization

- Mark Quick Appointed Chief Financial Officer, Bringing Extensive Public Company Capital Markets Expertise - - Current CFO, Stefano Picone, will take on a Transitional Strategic Role to Support Leadership...

CNVI.VN : 0.420 (-2.33%)
CNVIF : 0.3130 (+4.06%)
Conavi Medical announces agreement with the Province of Ontario as part of the Life Sciences Scale-Up Fund

TORONTO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing,...

CNVI.VN : 0.420 (-2.33%)
CNVIF : 0.3130 (+4.06%)
Conavi Medical to Highlight Novasight Hybrid™ Imaging at TCT 2025

TORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Inc. (TSXV: CNVI) (OTCQB: CNVIF), a commercial-stage medical device company focused on intravascular imaging solutions, today announced that...

CNVI.VN : 0.420 (-2.33%)
CNVIF : 0.3130 (+4.06%)
Conavi Medical to Present at the Planet MicroCap Showcase: TORONTO in partnership with MicroCapClub on Wednesday, October 22, 2025

TORONTO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing,...

CNVI.VN : 0.420 (-2.33%)
CNVIF : 0.3130 (+4.06%)
Conavi Medical Submits Next Generation Novasight Hybrid Intravascular Imaging System to US FDA for 510(k) Clearance

US FDA 510(k) Submission Follows the Successful Validation Testing with KOLs FDA 510(k) Clearance Anticipated During H1 2026 and Company Preparing for US Commercial Launch following Clearance ...

CNVI.VN : 0.420 (-2.33%)
CNVIF : 0.3130 (+4.06%)
Conavi Medical Reports Fiscal Q3 2025 Interim Results and Operational Highlights

US FDA 510(k) submission remains on track for calendar Q3 2025 Successful validation testing of Novasight Hybrid ™ system with key opinion leaders Recent academic publications underscore importance...

CNVI.VN : 0.420 (-2.33%)
CNVIF : 0.3130 (+4.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Conavi Medical Corp is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its Novasight Hybrid System is the first system to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable...

See More

Key Turning Points

3rd Resistance Point 0.427
2nd Resistance Point 0.423
1st Resistance Point 0.422
Last Price 0.420
1st Support Level 0.417
2nd Support Level 0.413
3rd Support Level 0.412

See More

52-Week High 0.710
Fibonacci 61.8% 0.572
Fibonacci 50% 0.530
Fibonacci 38.2% 0.488
Last Price 0.420
52-Week Low 0.350

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar